1. Efficacy and safety of eribulin in combination with trastuzumab in HER2-positive metastatic breast cancer patients: Real life experience. (October 2020) Authors: Kovalenko, E.; Manzyuk, L.; Gorbunova, V.; Kolyadina, I.; Bolotina, L.; Zhilyaeva, L.; Ponomarenko, D.; Karabina, E.; Mukhametshina, G.; Khasanova, A.; Ekaterina, R.; Safarova, A.; Manikhas, A.; Volkonsky, M.; Kramskaya, L.; Karandeeva, T.; Suslova, I.; Popova, N.; Evstigneeva, I.; Shumskaya, I. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗